EA201300479A1 - Соединения для применения в визуализации, диагностике и/или лечении заболеваний центральной нервной системы - Google Patents

Соединения для применения в визуализации, диагностике и/или лечении заболеваний центральной нервной системы

Info

Publication number
EA201300479A1
EA201300479A1 EA201300479A EA201300479A EA201300479A1 EA 201300479 A1 EA201300479 A1 EA 201300479A1 EA 201300479 A EA201300479 A EA 201300479A EA 201300479 A EA201300479 A EA 201300479A EA 201300479 A1 EA201300479 A1 EA 201300479A1
Authority
EA
Eurasian Patent Office
Prior art keywords
diagnostics
visualization
diseases
connections
treatment
Prior art date
Application number
EA201300479A
Other languages
English (en)
Other versions
EA023820B1 (ru
Inventor
Андреа Тиле
Георг Кеттшау
Тобиас Генрих
Лутц Леманн
Кристер Халльдин
Санграм Наг
Андреа Варроне
Балаж Гуляш
Original Assignee
Пирамаль Имэджинг Са
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пирамаль Имэджинг Са filed Critical Пирамаль Имэджинг Са
Publication of EA201300479A1 publication Critical patent/EA201300479A1/ru
Publication of EA023820B1 publication Critical patent/EA023820B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/001—Acyclic or carbocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/04—Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups
    • C07C209/14—Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups by substitution of hydroxy groups or of etherified or esterified hydroxy groups
    • C07C209/16—Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups by substitution of hydroxy groups or of etherified or esterified hydroxy groups with formation of amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/29—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Изобретение относится к новым соединениям, подходящим в качестве прекурсоров для изготовления соответствующих меченыхF радиоактивных индикаторов позитронно-эмисионной томографии (ПЭТ). Кроме того, изобретение относится к изготовлению указанных молекул прекурсора и к изготовлению радиоактивных индикаторов ПЭТ посредством мечения указанных прекурсоровF.
EA201300479A 2010-10-22 2011-10-17 Соединения для применения в визуализации, диагностике и/или лечении заболеваний центральной нервной системы EA023820B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10188559A EP2450332A1 (en) 2010-10-22 2010-10-22 Compounds for use in Imaging, diagnosing and/or treatment of diseases of the central nervous system (F-D2-Deprenyl)
PCT/EP2011/068124 WO2012052409A1 (en) 2010-10-22 2011-10-17 Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system

Publications (2)

Publication Number Publication Date
EA201300479A1 true EA201300479A1 (ru) 2013-10-30
EA023820B1 EA023820B1 (ru) 2016-07-29

Family

ID=43760025

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201300479A EA023820B1 (ru) 2010-10-22 2011-10-17 Соединения для применения в визуализации, диагностике и/или лечении заболеваний центральной нервной системы

Country Status (18)

Country Link
US (1) US9314540B2 (ru)
EP (2) EP2450332A1 (ru)
JP (1) JP5964840B2 (ru)
KR (1) KR101852647B1 (ru)
CN (2) CN103443056A (ru)
AR (1) AR083519A1 (ru)
AU (1) AU2011317664A1 (ru)
BR (1) BR112013009861A2 (ru)
CA (1) CA2815401C (ru)
DK (1) DK2630104T3 (ru)
EA (1) EA023820B1 (ru)
HK (1) HK1203190A1 (ru)
IL (1) IL225855A0 (ru)
MX (1) MX340487B (ru)
NZ (1) NZ610736A (ru)
SG (1) SG189478A1 (ru)
TW (1) TW201225979A (ru)
WO (1) WO2012052409A1 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2053033A1 (en) * 2007-10-26 2009-04-29 Bayer Schering Pharma AG Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors
WO2015143019A2 (en) * 2014-03-18 2015-09-24 Mayo Foundation For Medical Education And Research Gaseous f-18 technologies
MX2016014615A (es) 2014-05-13 2017-03-06 Hoffmann La Roche Compuestos heterociclicos deuterados y su uso como agentes formadores de imagenes.
CN107445798B (zh) * 2016-06-01 2020-11-03 中国农业大学 一种α,α‐二氘代醇类化合物的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ329471A (en) * 1995-03-02 1999-10-28 Scherer Ltd R P Use of monoamide oxidase b inhibitors to treat parkinson's disease
EP1104174A4 (en) * 1998-06-09 2006-08-02 Matsushita Electric Ind Co Ltd IMAGE CODERS, IMAGE DECODERS, CHARACTERS AND DATA STORAGE MEDIUM
EP2053033A1 (en) 2007-10-26 2009-04-29 Bayer Schering Pharma AG Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors
WO2010121719A1 (en) 2009-04-23 2010-10-28 Bayer Schering Pharma Aktiengesellschaft Novel precursor molecules for f-18 labelled pet tracers

Also Published As

Publication number Publication date
JP5964840B2 (ja) 2016-08-03
HK1203190A1 (en) 2015-10-23
CA2815401C (en) 2019-04-09
EA023820B1 (ru) 2016-07-29
KR20140023870A (ko) 2014-02-27
NZ610736A (en) 2014-11-28
AR083519A1 (es) 2013-03-06
MX2013004457A (es) 2013-09-16
TW201225979A (en) 2012-07-01
CN104478735A (zh) 2015-04-01
EP2450332A1 (en) 2012-05-09
EP2630104A1 (en) 2013-08-28
CN104478735B (zh) 2017-05-31
US20130336890A1 (en) 2013-12-19
CA2815401A1 (en) 2012-04-26
DK2630104T3 (en) 2018-07-16
US9314540B2 (en) 2016-04-19
EP2630104B1 (en) 2018-04-04
WO2012052409A1 (en) 2012-04-26
SG189478A1 (en) 2013-05-31
AU2011317664A1 (en) 2013-05-23
CN103443056A (zh) 2013-12-11
MX340487B (es) 2016-07-11
BR112013009861A2 (pt) 2019-09-24
KR101852647B1 (ko) 2018-04-26
JP2014502257A (ja) 2014-01-30
IL225855A0 (en) 2013-07-31

Similar Documents

Publication Publication Date Title
EA201100301A1 (ru) Daa-пиридин в качестве лиганда периферического бензодиазепинового рецептора для диагностической визуализации и фармацевтического лечения
MX2021008976A (es) Inhibidores marcados de antigeno prostatico especifico de membrama (psma), su uso como agentes formadores de imagenes y agentes farmaceuticos para el tratamiento de cancer de prostata.
EA201890915A1 (ru) Конъюгаты для доставки лекарственных средств и способы лечения заболеваний, вызванных клетками, экспрессирующими psma
MA34091B1 (fr) Anticorps anti-cd40
BR112012016376A2 (pt) compostos de pirrolo-aminopirimida substituída
EA202190619A1 (ru) Противовирусные соединения
BRPI0911383A2 (pt) miméticos de alfa hélice e métodos relacionados a eles
BR112015015528A8 (pt) composição e método para produzir um composto
PH12014502141A1 (en) New indanyloxydihydrobenzofuranylacetic acid derivatives and their use as gpr40 receptor agonists
EA201300388A1 (ru) Соединения замещенного бензамида
UA115122C2 (uk) Cd3-зв'язувальна молекула, здатна до зв'язування з cd3 людини і cd3, що не є людським
EA201200046A1 (ru) Новые соединения, фармацевтическая композиция и связанные с ними способы
EA201400165A1 (ru) Частицы на основе полиакрилата, которые содержат активное соединение
EA201492067A1 (ru) Применение связывающих семафорин-4d молекул для промотирования нейрогенеза после инсульта
MX2013011124A (es) Compuestos para el tratamiento del sindrome metabolico.
EA201300479A1 (ru) Соединения для применения в визуализации, диагностике и/или лечении заболеваний центральной нервной системы
AU2010332841A8 (en) Prostate specific membrane antigen inhibitors
FR2979346B1 (fr) Nanocorps anti-vcam-1
MX2019002620A (es) Métodos de síntesis química de compuestos de diaminofenotiazinio que incluyen cloruro de metiltioninio (mtc).
MX2013006202A (es) Metodo de radioconjugacion.
MX2013012795A (es) Procursores novedosos de derivados de glutamato.
EA201270817A1 (ru) Соединения, обладающие антибактериальной активностью в отношении clostridium
BR112013006498A2 (pt) composto
WO2012033374A3 (ko) 1,2,3-트리아졸륨 염을 갖는 설포네이트 전구체, 그 제조방법 및 이를 사용하는 분자내 친핵성 플루오르화반응
MX2013010781A (es) Compuestos para usarse en formacion de imagenes, diagnostico y/o tratamiento de enfermedades del sistema nervioso central.

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

TC4A Change in name of a patent proprietor in a eurasian patent